Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Partnership symbols : QGEN save search
QIAGEN announces partnership with Penn State University to advance microbiome sciences
Published: 2024-01-25 (Crawled : 15:00) - globenewswire.com
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 0.27%
H: 1.09%
C: 0.27%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 0.27%
H: 1.09%
C: 0.27%
partnership state sciences
QIAGEN and SOPHiA GENETICS Forge Partnership to Combine Strengths in Next-Generation Sequencing
Published: 2023-03-01 (Crawled : 16:00) - biospace.com/
SOPH | $5.055 -0.1% 7.4K
|
|
| O: 0.0%
H: 1.92%
C: 0.77%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 0.24%
H: 0.13%
C: -1.67%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 0.24%
H: 0.13%
C: -1.67%
partnership
SOPHiA GENETICS and QIAGEN Forge Partnership to Combine Strengths in Next-generation Sequencing
Published: 2023-03-01 (Crawled : 16:00) - biospace.com/
SOPH | $5.055 -0.1% 7.4K
|
|
| O: 0.0%
H: 1.92%
C: 0.77%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 0.24%
H: 0.13%
C: -1.67%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: 0.24%
H: 0.13%
C: -1.67%
partnership
Worldwide Companion Diagnostics Market to 2026 to be Driven by Significant Partnerships and Collaborations for Development
Published: 2021-09-06 (Crawled : 12:00) - prnewswire.com
QGEN | $41.505 -0.92% 610K
|
Health Technology
| Email alert
Add to watchlist
QGEN | $41.505 -0.92% 610K
|
Health Technology
| Email alert
Add to watchlist
DHR | $249.74 -1.33% 1.6M
|
Health Technology
| Email alert
Add to watchlist
MYGN | $18.65 0.27% 220K
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $106.74 -0.79% 3.3M
|
Health Technology
| Email alert
Add to watchlist
TMO | News | $576.17 0.27% 1.5M
|
Health Technology
| Email alert
Add to watchlist
partnership collaboration diagnostics diagnostic
QIAGEN, in partnership with DiaSorin, announces the launch of the new LIAISON® LymeDetect® Assay based on QuantiFERON technology in countries accepting CE Mark for early diagnosis of Lyme Borreliosis
Published: 2021-04-21 (Crawled : 07:00) - biospace.com/
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: -1.95%
H: 1.5%
C: 1.13%
QGEN | $41.505 -0.92% 610K
|
Health Technology
|
| O: -1.95%
H: 1.5%
C: 1.13%
partnership ce mark technology diagnostic
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CSSE 4 | $0.3831 151.54% 190M
|
Consumer Services
CZOO | $11.04 121.24% 11M
|
LICN | $0.9107 62.63% 14M
|
BOF | $1.87 59.83% 100M
|
AMST | $3.18 59.0% 67M
|
Technology Services
SKIL 4 | $8.72 52.72% 410K
|
Information
MTC | $3.31 47.77% 7.7M
|
Technology Services
MULN | News | $3.915 43.41% 12M
|
Information
WIMI | $1.04 43.37% 17M
|
Technology Services
RILY | $29.755 36.99% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.